emphysematous cholecystitis
Recently Published Documents


TOTAL DOCUMENTS

265
(FIVE YEARS 39)

H-INDEX

16
(FIVE YEARS 1)

Cureus ◽  
2021 ◽  
Author(s):  
Anuj Kunadia ◽  
Michael B Leong ◽  
Karthikram Komanduri ◽  
Randa Abdelmasih ◽  
Aneta Tarasiuk-Rusek

2021 ◽  
Vol 9 (6) ◽  
Author(s):  
Ashesha Mechineni ◽  
Rajapriya Manickam ◽  
Balraj Singh

2021 ◽  
Vol 44 (1) ◽  
pp. 25-27
Author(s):  
I Garrido Márquez ◽  
Á Moyano Portillo ◽  
E Moya Sánchez

Resumen La colecistitis enfisematosa es una presentación infrecuente de la colecistitis aguda, consistente en una inflamación de la vesícula biliar con presencia de gas en su pared, en su luz, o en ambas. Su diagnóstico se realiza mediante pruebas de imagen, si bien existen algunas patologías que pueden dar hallazgos similares y crear confusión, como es el caso de las fístulas bilioentéricas, que consisten en una comunicación anormal entre el sistema biliar y el tracto gastrointestinal que ocurre de forma espontánea. Las imágenes mediante tomografía computarizada suelen ser patognomónicas, siendo el tratamiento quirúrgico definitivo.


2021 ◽  
Vol 2021 (3) ◽  
Author(s):  
Hitoshi Funahashi ◽  
Tetsuya Komori ◽  
Naoki Sumita

Abstract Emphysematous cholecystitis (EC) is a severe and rare variant of acute cholecystitis characterized by ischemia of the gallbladder wall with gas-forming bacterial proliferation. Open cholecystectomy is traditionally the gold standard approach to treatment due to difficulty in isolating Calot’s triangle in the setting of intense inflammation. We present a case of EC successfully and safely treated by laparoscopic surgery.


Author(s):  
Adnan Yamanoğlu ◽  
Serkan Bilgin ◽  
Nalan Gokce Çelebi Yamanoğlu ◽  
Fatih Esad Topal

2021 ◽  
Vol 99 (2) ◽  
pp. 167-168
Author(s):  
Javier Gómez Sánchez ◽  
Juan Alfredo Ubiña Martínez ◽  
Fernando Expósito Sequera

Author(s):  
Ashesha Mechineni ◽  
Balraj Singh ◽  
Rajapriya Manickam

Emphysematous cholecystitis is caused by gas-forming micro-organisms, primarily in patients with immunosuppression and diabetes mellitus. It leads to a signature radiological finding with air in gall bladder wall as described in this report. Clinicians should be aware of this critical differential diagnosis.


2021 ◽  
Vol 8 (2) ◽  
pp. 463
Author(s):  
Ramiz Iqbal ◽  
Elvina Wiadji

Background: Emphysematous cholecystitis (EC) is a rare variant of acute cholecystitis with a reported 15-25% mortality rate. Conventionally, EC is managed with an early open cholecystectomy. However, recent advancement in percutaneous intervention and laparoscopic techniques have influenced our management of this biliary pathology. This study reviews the management and outcomes of EC in a regional centre.Methods: Retrospective analysis of a clinical database constituting all patients diagnosed with EC at a regional Australian hospital in NSW from Jan 2010 to July 2019. Inclusion criteria: sepsis, abdominal pain and radiological evidence of gas in the gallbladder wall, lumen, and pericholecystic tissue in the absence of an abnormal connection between the gallbladder and gastrointestinal tract. We investigated patient risk factors, management and outcomes.Results: 16 patients with EC were identified. The mean age of the cohort was 73 years old. The majority of patients had co-morbidity including type 2 diabetes and ischemic heart disease (56 and 62% respectively). Laparoscopic cholecystectomies were performed in 9 patients during their index admissions and 7 patients were managed with PTC. 5 patients required ICU admission for septic shock, and all were managed with PTC drain placement. The overall mortality rate was 6%.Conclusions: Laparoscopic cholecystectomy on index admission is the treatment of choice for EC. Although more technically challenging, adverse clinical event including major complication and open conversion was avoided in our cohort while percutaneous cholecystostomy was reserved for unstable and poor surgical candidate.


Sign in / Sign up

Export Citation Format

Share Document